Pegylated liposomal doxorubicin in combination with cyclophosphamide and trastuzumab in HER2-positive metastatic breast cancer patients: efficacy and cardiac safety from the GEICAM/2004–05 study
Titel:
Pegylated liposomal doxorubicin in combination with cyclophosphamide and trastuzumab in HER2-positive metastatic breast cancer patients: efficacy and cardiac safety from the GEICAM/2004–05 study
Auteur:
Martín, M. Sánchez-Rovira, P. Muñoz, M. Baena-Cañada, J.M. Mel, J.R. Margeli, M. Ramos, M. Martínez, E. García-Saenz, J.A. Casado, A. Jaén, A.M. González-Farré, X. Escudero, M.J. Rodriguez-Martin, C. Carrasco, E.